- Report
- May 2026
- 181 Pages
Netherlands
From €4407EUR$4,850USD£3,788GBP
- Report
- May 2026
- 184 Pages
South Africa
From €4407EUR$4,850USD£3,788GBP
- Report
- January 2026
- 150 Pages
India
From €4407EUR$4,850USD£3,788GBP
- Report
- September 2025
- 150 Pages
China
From €4407EUR$4,850USD£3,788GBP
- Report
- August 2023
- 106 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- July 2023
- 153 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- October 2023
- 133 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- February 2023
- 86 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- November 2025
- 132 Pages
Global
From €863EUR$950USD£742GBP
The Infant Phototherapy Device market is a segment of the Medical Devices industry that focuses on the treatment of newborns with jaundice. Phototherapy is a non-invasive procedure that uses light to reduce the level of bilirubin in the blood. Infant Phototherapy Devices are designed to provide a safe and effective treatment for newborns with jaundice. These devices typically include a light source, a timer, and a light shield to protect the infant's eyes.
Infant Phototherapy Devices are used in hospitals, neonatal intensive care units, and other healthcare settings. They are designed to be easy to use and provide a safe and effective treatment for newborns with jaundice.
Some companies in the Infant Phototherapy Device market include Philips Healthcare, GE Healthcare, Dräger Medical, Natus Medical, and BiliBlanket. Show Less Read more
